[ Follow Ups ] [ Post Followup ] [ Main Board ]

Another study that appears to be promising for long term...

Posted by sm on Sat, Aug 14 2021 at 02:11 PM CDT:

In Reply to: There is data, yes, conflicting data and incomplete data. posted by Amost no one has had natural immunity for more than a year and a half, sm on Sat, Aug 14 2021 at 09:47 AM CDT:

A sophisticated team of researchers operating at Fred Hutchinson Cancer Research Center and Emory University suggest that transcending the COVID-19 pandemic necessitates what they refer to as “long-lived immunity to SARS-CoV-2.” Leading a longitudinal study involving 254 COVID-19 patients over an eight-month period, the study team observed what they referred to as “durable broad-based immune responses” in those mild-to-moderate COVID-19 patients. The investigators remind all that this class of infection represents the vast majority of cases. Although still not peer-reviewed—hence the findings are by no means verified—they do articulate that the prospects look promising as a confluence of factors indicates those infected with SARS-CoV-2 indicate “broad and effective immunity” that could “persist long-term in recovered COVID-19 patients.” The findings, of course, must be reviewed and confirmed, and the authors’ views don’t necessarily reflect those of the academic medical centers that employ them. TrialSite suggests if these findings hold up, they represent powerfully positive information for further study. The study authors will continue tracking the population for two years.

Follow Ups:

Post a Followup




Optional Link URL:
Link Title:
Optional Image URL:

[ Follow Ups ] [ Post Followup ] [ Main Board ]